Jun. 2, 2003—Vanderbilt University Medical Center is one step closer to changing the way doctors look at coronary arteries.
Jun. 2, 2003—A reorganization of the offices that oversee the commercialization of Vanderbilt research discoveries and inventions will result in a more streamlined process for the transfer of new technologies to the marketplace, according to a plan announced today by University officials.
May. 30, 2003—Vanderbilt University Medical Center has been ranked No. 3 worldwide in enrollment for an international trial testing the efficacy of a new immunosuppressant drug for use in heart transplant patients.
May. 30, 2003—Parents and students seeking active ways to enjoy the long, hot summer can find a number of options online in the Directory of Out-of-School Activities.
May. 29, 2003—Mark Cohen has been appointed senior associate dean at Vanderbilt Universitys Owen Graduate School of Management, effective July 1.
May. 28, 2003—Vanderbilt's first robotic surgical procedure was performed in mid May by Dr. Joseph A. Smith Jr., William L. Bray Professor and Chair of Urologic Surgery. Smith used VUMC's new $1 million-plus Da Vinci Surgical System, built by Intuitive Surgical, to perform a radical prostatectomy.
May. 27, 2003—Divinity School Dean James Hudnut-Beumler announced that John S. McClure will lead one of the most unique programs in the country for educating and placing future professors of preaching and worship the beginning with the fall semester.
May. 27, 2003—Vanderbilt and Meharry have been collaborating with NIH for several years on research involving HIV/AIDS, which is spread primarily by sexual contact and intravenous drug use. The goal of the new grant is to encourage further collaboration between the schools, and train new investigators to advance AIDS treatment and prevention.
May. 22, 2003—Arguments for and against genetically altering plants, fruits and vegetables continue.
May. 21, 2003—Directors of publicly traded companies will gather at Vanderbilt University Law School in June to address the issues directors now face as a result of recent regulatory changes in a climate of investor uncertainty.